Evidence map›Paper›PMID 42245691›Full record

ArticleFrontiers in oncology2026

Case Report: Cardiac metastasis from urothelial carcinoma with predominant squamous differentiation in a young woman: first reported case treated with enfortumab vedotin plus pembrolizumab.

Alix Vansteeger, El Mamoune El Ghali Benlemlih, Antoine Delmarche, Stéphane Thiry, Hélène Dano, Justine Castaigne, Vassiliki Pasoglou, Sandy Van Nieuwenhove, Bernhard Gerber, Gaby Aphram and 5 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alix VansteegerInstitut Roi Albert II, Medical Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
El Mamoune El Ghali BenlemlihInstitut Roi Albert II, Medical Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Antoine DelmarcheDepartment of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Stéphane ThiryDepartment of Urology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Hélène DanoDepartment of Pathology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Justine CastaigneInstitut Roi Albert II, Medical Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Vassiliki PasoglouDepartment of Radiology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Sandy Van NieuwenhoveDepartment of Radiology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Bernhard GerberCardiovascular Department, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Gaby AphramDepartment of Cardiovascular Surgery, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Qaid Ahmed ShageraDepartment of Nuclear Medicine, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Christophe BeauloyeCardiovascular Department, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Rachel GalotInstitut Roi Albert II, Medical Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Cédric van MarckeInstitut Roi Albert II, Medical Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
Emmanuel SerontInstitut Roi Albert II, Medical Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac metastases from urothelial carcinoma (UC) are rare and have a poor prognosis. A 36-year-old woman presented with

Indexed as

cardiac metastasisenfortumab-pembrolizumabsquamous differentiationsurgeryurothelial carcinoma

Identifiers

PMID42245691
PMCPMC13229814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.